top of page
LuTra
Studio
LLC


Transforming Ideas into Impact.
Turning deep science, business insight, and career strategy into clear next steps.


How Amino Acids Enhance LNP mRNA Delivery: A New Direction for mRNA Therapeutics
Introduction How Amino Acids Enhance LNP mRNA Delivery: A New Direction for mRNA Therapeutics Over the past few years, lipid nanoparticles (LNPs) have become the cornerstone of modern mRNA therapeutics. From COVID-19 mRNA vaccines to cancer immunotherapy, rare disease treatment, and gene editing, LNPs are now one of the most important delivery platforms for nucleic acid medicines. But anyone who has worked in drug delivery knows a frustrating reality: An LNP system that perfo

Jason Lu
May 96 min read


ADC Series (IX) ADC Manufacturing & CMC:How Antibody–Drug Conjugates Are Produced at Scale
Executive Summary Antibody–drug conjugates (ADCs) hold tremendous promise in both scientific innovation and clinical applications, but they also present significant challenges in manufacturing. Compared to traditional biologics or small-molecule drugs, ADC production involves: biologics (antibodies) highly potent small molecules (payloads) complex conjugation chemistry As a result, ADC manufacturing and CMC (Chemistry, Manufacturing, and Controls) often become critical bottl

Jason Lu
Mar 293 min read


The Rise of mRNA Therapeutics: From Genetic Messenger to a Transformative Medical Platform
Introduction Messenger RNA (mRNA), once a niche topic confined to molecular biology laboratories, has rapidly emerged as one of the most transformative technologies in modern medicine. While the COVID-19 pandemic brought mRNA vaccines into the global spotlight, their success was not an overnight miracle—it was the culmination of decades of foundational research, engineering breakthroughs, and persistent efforts to overcome the inherent fragility of RNA. Today, mRNA therapeuti

Jason Lu
May 18, 20255 min read
bottom of page